NP Resources & Guides

Arizona is a Full Practice Authority state where nurse practitioners can practice independently without physician supervision. However, obtaining prescriptive authority—especially for controlled substances—requires understanding Arizona's unique regulatory framework including certification requirements, DEA registration, and CSPMP compliance. This comprehensive 2026 guide covers Arizona NP collaboration requirements, when collaboration is beneficial or required, prescriptive authority protocols, controlled substance regulations (Schedule II-V), market rates for collaborating physicians ($500-$1,400/month across specialties), and how NPCollaborator connects Arizona NPs with pre-vetted, specialty-matched physicians in 48-72 hours. Essential reading for NPs practicing in Phoenix, Tucson, Scottsdale, Mesa, and throughout Arizona.

South Carolina requires formal physician collaboration for nurse practitioner practice. This comprehensive guide explains SC collaboration laws, written practice agreements, supervision requirements, costs, and compliance essentials.

Delaware operates under Reduced Practice Authority for APRNs. New nurse practitioners must practice under a collaborative protocol with a physician for at least 2 years and 4,000 hours before qualifying for Independent Prescriptive Authority (IPA). This 2026 guide explains Delaware's unique two-tier system (CP to IPA), Joint Practice Committee approval process, controlled substance prescribing restrictions, market rates ($650-$1,650/month), and how NPCollaborator streamlines finding Delaware-licensed collaborating physicians.

Explore our comprehensive Delaware Collaborating Physician State Guide for nurse practitioners. Learn about collaboration requirements, practice regulations, physician agreements, and how NP Collaborator helps connect NPs with experienced collaborating physicians across Delaware.

Hawaii is a Full Practice Authority state—APRNs can diagnose, treat, and prescribe independently without statutory collaboration requirements. However, most hospitals, insurance panels (HMSA, Kaiser, UnitedHealthcare), and healthcare systems still require collaborative agreements for credentialing and risk management. This 2026 guide covers Hawaii's APRN-Rx prescriptive authority, why voluntary collaboration matters, inter-island practice considerations, market rates ($700-$1,750/month), and how to find Hawaii-licensed collaborating physicians through NPCollaborator.

Comprehensive 2026 guide for Georgia nurse practitioners covering physician delegation requirements, APRN protocol agreements, legal frameworks, costs, and step-by-step compliance strategies. Includes detailed legal breakdown, case studies, FAQs, and a comprehensive table.

Colorado is a Full Practice Authority state, but NPs must complete a structured 750-hour mentorship program (RXN-P) to obtain full prescriptive authority. This 2026 guide explains Colorado's Articulated Plan of Safe Prescribing requirements, controlled substance prescribing protocols, chart review expectations, market rates for physician mentors ($500-$1,400/month), and how NPCollaborator connects Colorado NPs with pre-vetted mentors in 48-72 hours.

Tennessee requires an ongoing Collaborative Management Agreement with a collaborating physician for NP practice. NPs do not have full practice authority under current Tennessee law, and key compliance areas include chart review, prescriptive approvals, and remote-practice obligations where applicable.

Wisconsin's APRN practice landscape is defined by a critical transition. Through August 31, 2026, all APNPs must maintain a documented collaborative relationship with a physician or dentist under Wis. Stat. ch. 441 and Wis. Admin. Code ch. N 8. The APRN Modernization Act, effective September 1, 2026, introduces an independence pathway—but only after satisfying dual 3,840-hour requirements with Board-approved documentation. Wisconsin imposes no ratio caps or geographic restrictions, tracks gabapentin alongside Schedules II–V in the ePDMP, and requires ongoing physician collaboration for invasive pain management outside hospitals regardless of independence status.

Wyoming offers nurse practitioners full independent practice authority, with no physician oversight or collaborative practice agreement required. NPs may evaluate, diagnose, order tests, and prescribe Schedule II–V controlled substances when they maintain an APRN license, Wyoming Controlled Substance Registration, and federal DEA registration. Key compliance obligations include renewing the state controlled substance credential every two years, completing three hours of controlled-substance-or-substance-abuse-treatment CE biennially, fulfilling one-time federal MATE Act training, and querying PMP AWARxE before controlled-substance prescribing.

Washington ARNPs generally practice without a required collaborating physician, as state law recognizes independent authority under RCW 18.79.050 and WAC 246-840-300. ARNPs may evaluate, diagnose, treat, and prescribe within scope, including Schedule II–V controlled substances, provided DEA registration is active. Compliance obligations include a one-time 4-hour opioid prescribing CE, individual PMP registration, mandatory electronic prescribing for controlled substances since January 2022, and federal MATE Act training. Voluntary physician collaboration remains common for specialty consultation or credentialing.

West Virginia is a restricted-practice state requiring NPs to maintain a notarized, board-filed collaborative practice agreement under W. Va. Code § 30-7-15b for prescriptive authority. Schedule II narcotics are statutorily capped at a three-day supply, with no exceptions. NPs must register with the CSMP, hold DEA registration, and complete MATE Act training. After three years of documented collaborative practice, NPs may apply for independent prescriptive authority, though CS registration and the Schedule II limit remain in effect.